An Inspiring Evening with Dr. Stephen Sallan: The History of Curing Childhood Cancers

Childhood leukemia was a universally fatal disease in the 1940s. From the first use of chemotherapy in the treatment of childhood leukemia in 1947 to today’s 5-year cure rate of 90 percent, Stephen E. Sallan, MD, the Quick Family Chair in Pediatric Oncology at Dana-Farber, will walk us through the revolutionary breakthroughs forged by Dana-Farber and others to combat pediatric leukemia. Join us for an inspiring conversation with Dr. Sallan and Dr. Scott Armstrong, President of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, to learn about how leading physician-scientists have transformed the groundbreaking discoveries made by founder Dr. Sidney Farber, and where the field is headed to continue improving survival rates and quality of life for all children with cancer.

To learn more, visit the Revolutionary Science section of this site.

Give Now

Thank you for your interest in learning more about The Dana-Farber Campaign. You have been added to our email list and will receive updates on ways to join us in defying cancer. You can unsubscribe at any time.

There has been an issue submitting your request. Please try again.

Founded in Boston in 1947, Dana-Farber is a principal teaching affiliate of Harvard Medical School and a federally designated Comprehensive Cancer Center that develops and disseminates innovative patient therapies and scientific discoveries throughout the world. About Our Patient Stories: Dana-Farber shares patient stories which may include descriptions of actual medical results. Dana-Farber provides personalized care for each patient based on their unique needs; their experiences and results will vary.

At Dana-Farber we are committed to an inclusive community where human differences are valued and celebrated, and where all are welcome. We work every day to create an innovative, caring, and inclusive environment where each patient, family, and staff member feels valued and respected.